Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences

ROCKVILLE, Md.--(Business Wire)--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be
webcasting its presentation at the following investor conferences during the
month of November 2009.

* The Southwest Ideas Conference
Dallas, TX.
November 11, 2009
Presentation Time: 11:30 AM Central

* The 6th Annual Lazard Capital Markets Healthcare Conference
New York, NY.
November 17, 2009
Presentation Time: 8:55 AM Eastern

During each presentation, a member of the company`s senior management team will
provide a corporate overview, including a discussion of product development
programs, corporate activities and financial performance.

A webcast of these presentations will be available both live and by replay,
accessible from the company`s website www.emergentbiosolutions.com under
"Investors".

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of vaccines and therapeutics that
assist the body`s immune system to prevent or treat disease. Emergent`s marketed
product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by
the U.S. Food and Drug Administration for the prevention of anthrax disease.
Emergent`s development pipeline includes programs focused on anthrax, botulism,
tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be
found at www.emergentbiosolutions.com.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Director, Corporate Communications
301-795-1800
SchmittT@ebsi.com

Copyright Business Wire 2009